Paroxysmal nocturnal hemoglobinuria screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==Screening== | ==Screening== | ||
* According to the American society of hematology, screening for paroxysmal nocturnal hemolglobinuria is recommended among patients with: | |||
** Cytopenia | |||
** Suspected Myelodysplasia | |||
According to the | |||
* | |||
* | |||
* | |||
==References== | ==References== |
Revision as of 17:03, 10 August 2018
Paroxysmal nocturnal hemoglobinuria Microchapters |
Differentiating Paroxysmal nocturnal hemoglobinuria from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paroxysmal nocturnal hemoglobinuria screening On the Web |
American Roentgen Ray Society Images of Paroxysmal nocturnal hemoglobinuria screening |
Directions to Hospitals Treating Paroxysmal nocturnal hemoglobinuria |
Risk calculators and risk factors for Paroxysmal nocturnal hemoglobinuria screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Screening
- According to the American society of hematology, screening for paroxysmal nocturnal hemolglobinuria is recommended among patients with:
- Cytopenia
- Suspected Myelodysplasia